Seven small Australian biotechs changed hands since late 2024 — four deals closed, three still pending

Asked:

“Recently acquired biotech companies in Australia with under 100 employees”

An evidence-backed screen of Australian biotech and closely related life-sciences companies found 7 whole-company or control acquisitions since 2024 where separate sourcing put the target under 100 employees. 34 plausible transaction candidates were screened; companies without usable under-100 headcount evidence were left out, so this is a researched shortlist, not an exhaustive census. “Recent” means announced or completed from 2024 onward. Minority stakes, licensing deals and asset-only purchases were excluded.

completed acquisition announced / agreed, not yet closed bar length = reported employee count (midpoint used for the 11–50 range)

The newest qualified deal is BASF’s purchase of biocontrol maker AgBiTech, completed 31 March 2026 — the target reported 44 staff as of end-2022. agri-ai-summit.com

Extractas Bioscience (Tasmania, ~85 staff) carries the largest disclosed price in the set: Siegfried’s USD 100 million deal announced January 2026 — headcount rests on a single source. pharmamanufacturing.com

Seer Medical’s displayed figure of 17 covers U.S.-based staff only; a second staffing source placed total March 2026 headcount at 91 — still under 100. businessnewsaustralia.com

Bionomics’ sources disagree on the exact count; the displayed one-person estimate is low-confidence, though all six sources place it below 100. biobase.whitefordresearch.com

All seven qualified deals

Target	Acquirer	Date	Status	Location	Employees (as of)	Deal value	Deal source	Staffing source

Method: researched shortlist of Australian biotech / life-sciences acquisitions, 7 rows, deals dated December 2024 to March 2026, compiled 2026. 34 candidate transactions were screened; only whole-company or control deals with separate under-100 headcount evidence are included. Employee figures are source estimates or stated ranges and may not be contemporaneous with the deal; dates shown where available. Business descriptions shortened for space.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.